2022 annual financial data
XORTX Therapeutics 2022 Net margin
XORTX Therapeutics 2022 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -12,433,624 CAD and net income was -6,988,880 CAD.
Operating cash flow was -8,165,959 CAD.
Get free XORTX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -12,433,624 CAD
- Net income
- -6,988,880 CAD
- Operating cash flow
- -8,165,959 CAD